Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's DiseaseAlzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyRecruitingPhase 1 / Phase 22026-09-18NCT07599670

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
AbbVie340

13 results · Page 1 of 1

Swipe the table sideways for more columns.